Oragenics, Inc.
Oragenics, Inc. (OGEN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · OGEN · as of Jun 8, 2026
Key Statistics
Explore Oragenics, Inc. Data
ogen stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 3 · Buy rate: 0.0%
Competitors & Peers
ogen competitorsOGEN
AIM
CANF
CNSP
ENSC
KALAStock Performance
Full HistoryAbout Oragenics, Inc.
Oragenics, Inc. (OGEN) is a U.S.-based biotechnology firm primarily focused on creating treatments for infectious diseases. Among its pipeline assets are two vaccine candidates designed to combat the …
what is oragenics, inc. · ogen stock overview · oragenics, inc. company profile · who is oragenics, inc. ceo · ogen AMEX · oragenics, inc. headquarters · oragenics, inc. business segments
About Stock Overview & Key Data
Oragenics, Inc. (OGEN) is a Healthcare company in the Biotechnology industry, listed on AMEX since Feb 25, 2004. As of the latest trading session, OGEN stock price is $0.61, with a market capitalization of $2.8M. The stock has returned -85.92% over the past 12 months and -22.18% year-to-date.
According to 3 Wall Street analysts, the consensus rating for Oragenics, Inc. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Oragenics, Inc. reported revenue of — and net income of -$9.8M. For detailed data — including Oragenics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Oragenics, Inc. (OGEN) stock price is $0.61. The stock is traded on AMEX under the ticker symbol OGEN. The 52-week range is $0.50 – $5.24.